282 related articles for article (PubMed ID: 22348394)
1. Blood vessels as targets in tumor therapy.
Claesson-Welsh L
Ups J Med Sci; 2012 May; 117(2):178-86. PubMed ID: 22348394
[TBL] [Abstract][Full Text] [Related]
2. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
3. [Tumor angiogenesis].
Bikfalvi A
Bull Cancer; 2007; 94(7 Suppl):F193-8. PubMed ID: 17964996
[TBL] [Abstract][Full Text] [Related]
4. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.
Lopes-Coelho F; Martins F; Pereira SA; Serpa J
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916438
[TBL] [Abstract][Full Text] [Related]
5. Anti-VEGF/VEGFR therapy for cancer: reassessing the target.
Sitohy B; Nagy JA; Dvorak HF
Cancer Res; 2012 Apr; 72(8):1909-14. PubMed ID: 22508695
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic and lymphangiogenic cascades in the tumor microenvironment.
Onimaru M; Yonemitsu Y
Front Biosci (Schol Ed); 2011 Jan; 3(1):216-25. PubMed ID: 21196371
[TBL] [Abstract][Full Text] [Related]
7. Vascular phenotype identification and anti-angiogenic treatment recommendation: A pseudo-multiscale mathematical model of angiogenesis.
Hutchinson LG; Gaffney EA; Maini PK; Wagg J; Phipps A; Byrne HM
J Theor Biol; 2016 Jun; 398():162-80. PubMed ID: 26987523
[TBL] [Abstract][Full Text] [Related]
8. Normalization of the vasculature for treatment of cancer and other diseases.
Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
[TBL] [Abstract][Full Text] [Related]
9. Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma.
Levine HA; Pamuk S; Sleeman BD; Nilsen-Hamilton M
Bull Math Biol; 2001 Sep; 63(5):801-63. PubMed ID: 11565406
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis-related pathways in the pathogenesis of ovarian cancer.
Gavalas NG; Liontos M; Trachana SP; Bagratuni T; Arapinis C; Liacos C; Dimopoulos MA; Bamias A
Int J Mol Sci; 2013 Jul; 14(8):15885-909. PubMed ID: 23903048
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.
Presta M; Dell'Era P; Mitola S; Moroni E; Ronca R; Rusnati M
Cytokine Growth Factor Rev; 2005 Apr; 16(2):159-78. PubMed ID: 15863032
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms and clinical applications of angiogenesis.
Carmeliet P; Jain RK
Nature; 2011 May; 473(7347):298-307. PubMed ID: 21593862
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic therapies in cancer: achievements and open questions.
Ruegg C; Mutter N
Bull Cancer; 2007 Sep; 94(9):753-62. PubMed ID: 17878094
[TBL] [Abstract][Full Text] [Related]
15. Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges.
Siveen KS; Prabhu K; Krishnankutty R; Kuttikrishnan S; Tsakou M; Alali FQ; Dermime S; Mohammad RM; Uddin S
Curr Vasc Pharmacol; 2017; 15(4):339-351. PubMed ID: 28056756
[TBL] [Abstract][Full Text] [Related]
16. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
17. Regulation of tumor angiogenesis by the local environment.
Hall K; Ran S
Front Biosci (Landmark Ed); 2010 Jan; 15(1):195-212. PubMed ID: 20036815
[TBL] [Abstract][Full Text] [Related]
18. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
Viallard C; Larrivée B
Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
[TBL] [Abstract][Full Text] [Related]
19. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
Leite de Oliveira R; Hamm A; Mazzone M
Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
[TBL] [Abstract][Full Text] [Related]
20. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
